EVERYTHING IS WRONG. PLEASE CONFIRM THAT YOU CAN SEE OUR WHOLE CHAT
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
You're right to call me out. Let me be direct:
I can see the system note that says you have a pT3a N0 M0 prostate cancer history, and that you've asked about 0.012 ng/mL and PSA trajectory calculations.
BUT — I cannot see your actual uploaded [ID removed] your complete PSA values, dates, or the full conversation history where you shared these details.
The system is telling me what you asked about, but not showing me the actual data you provided.
What I Need From You:
Can you please paste or re-share in THIS message:
-
Your complete PSA timeline (with dates)
- Example: Sept 2024: 0.004 | Feb 2025: 0.007 | May 2026: 0.012
-
Your RP date and any treatments since
-
Your specific question right now — what are you trying to figure out?
-
Any lab reports or pathology details you want me to interpret
Once you give me that information directly in this conversation, I can:
- ✅ Interpret YOUR actual values (not generic examples)
- ✅ Calculate YOUR specific PSA trajectory
- ✅ Explain what 0.012 means FOR YOUR CASE
- ✅ Answer your baseline question with YOUR data
I'm ready — please share the specific numbers and dates you're working with.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Have a similar question?
Ask Navis — our AI assistant — about your specific situation.
Ask Your Own QuestionRelated Questions
YOU STOPPED AT: C9: Why Your PSA Response Proves the Margin is Not Clinically Significant The Logic: WHAT A...
--- C9: Why Your PSA Response Proves the Margin is Not Clinically Significant CONTINUED The Logic: ``` WHAT A POSITIVE/CLOSE MARGIN MEANS: Theore
YOU STOPPED AT: Critical Finding: BIOCHEMICAL RECURRENCE RISK BY PSA NADIR (in patients with positive/close...
--- C3: How PSA Response Modifies Margin Risk CONTINUED Reference: "PSA Nadir Overcomes Margin Positivity" Study Details: - Published in: European
YOU STOPPED AT: B8: Direct Answer to Your Question "Does my PSA nadir of 0.004 ng/mL define me as 'VERY LOW RISK'...
--- B8: Direct Answer to Your Question CONTINUED "Does my PSA nadir of 0.004 ng/mL define me as 'VERY LOW RISK' or 'FAVORABLE INTERMEDIATE RISK' fo
YOU STOPPED AT: Clinical Significance: According to **"PSA Nadir as Prognostic Factor". PLEASE CONTINUE. THANKS
--- B3 CONTINUED: Risk Classification with PSA Nadir 0.004 ng/mL 130 Days Clinical Significance: "PSA Nadir as Prognostic Factor" Reference: "PSA
A) QUESTION: IS THE PERIOD OF 304 DAYS FROM SURGERY, WITH A FOLLOW-UP PSA TEST VALUE OF 0.007ng/mL, SUFFICIENT TO...
Your Complete Clinical Classification Timeline --- CRITICAL CLARIFICATION: YOUR PATHOLOGICAL STAGE Before addressing your excellent questions, I m